UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3210-3218

2001

Volltextzugriff (PDF)

Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation

Thrombosis and haemostasis, 2002-08, Vol.88 (2), p.213

2002

Volltextzugriff (PDF)

Twice-Weekly Paclitaxel and Weekly Carboplatin With Concurrent Thoracic Radiation Followed by Carboplatin/Paclitaxel Consolidation for Stage III Non–Small-Cell Lung Cancer: A California Cancer Consortium Phase II Trial

Journal of clinical oncology, 2001-01, Vol.19 (2), p.442-447

2001

Volltextzugriff (PDF)

Phase I Trial of the Combination of Irinotecan, Paclitaxel, and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1078-1087

2001

Volltextzugriff (PDF)

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma

Cancer, 2002-10, Vol.95 (7), p.1520-1527

2002

Volltextzugriff (PDF)

Phase 2 study of cryptophycin 52 ( LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-02, Vol.39 (2), p.197-199

2003

Volltextzugriff (PDF)

Phase II Study of Liposomal Doxorubicin in Advanced Gynecologic Cancers

Gynecologic oncology, 2000-08, Vol.78 (2), p.143-147

2000

Volltextzugriff (PDF)

Tamoxifen‐associated venous thrombosis and activated protein C resistance due to factor V leiden

Cancer, 1997-05, Vol.79 (10), p.2024-2027

1997

Volltextzugriff (PDF)

Phase II Study of Gemcitabine and Cisplatin in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group Study 9718

Journal of thoracic oncology, 2007-05, Vol.2 (5), p.440-444

2007

Volltextzugriff (PDF)

Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)

Investigational new drugs, 2004-08, Vol.22 (3), p.291-297

2004

Volltextzugriff (PDF)

MDR1 gene expression in primary and advanced breast cancer

Laboratory investigation, 1999-03, Vol.79 (3), p.271

1999

Volltextzugriff (PDF)

Gemcitabine in Patients with Non–Small-Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: A Phase II California Cancer Consortium Trial

Clinical lung cancer, 2004-09, Vol.6 (2), p.102-107

2004

Volltextzugriff (PDF)

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II california cancer consortium trial

Cancer chemotherapy and pharmacology, 2001-07, Vol.48 (1), p.22-28

2001

Volltextzugriff (PDF)

Phase I/II trial of irinotecan, carboplatin, and paclitaxel in advanced or metastatic NSCLC

Oncology (Williston Park, N.Y.), 2000-07, Vol.14 (7 Suppl 5), p.29

2000

Volltextzugriff (PDF)

Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trial

Clinical lung cancer, 2001-05, Vol.2 Suppl 2, p.S26-S33

2001

Volltextzugriff (PDF)

Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity : a pharmacokinetic and toxicity study

Cancer chemotherapy and pharmacology, 1995-01, Vol.37 (1-2), p.32-38

1995

Volltextzugriff (PDF)

Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections

Current topics in medicinal chemistry, 2017-04, Vol.17 (10), p.1157

2017

Volltextzugriff (PDF)

Bordetella bronchiseptica exploits the complex life cycle of Dictyostelium discoideum as an amplifying transmission vector

PLoS biology, 2017-04, Vol.15 (4), p.e2000420-e2000420

2017

Volltextzugriff (PDF)

A pilot randomized controlled trial to improve sleep and fatigue in children with central nervous system tumors hospitalized for high‐dose chemotherapy

Pediatric blood & cancer, 2019-08, Vol.66 (8), p.e27814-n/a

2019

Volltextzugriff (PDF)

Relationship between circadian activity rhythms and fatigue in hospitalized children with CNS cancers receiving high-dose chemotherapy

Supportive care in cancer, 2020-03, Vol.28 (3), p.1459-1467

2020

Volltextzugriff (PDF)

Interactions Between the Dietary Polyunsaturated Fatty Acid Ratio and Genetic Factors Determine Susceptibility to Pediatric Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2014-04, Vol.146 (4), p.929-931.e3

2014

Volltextzugriff (PDF)

Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals

BMJ open, 2021-07, Vol.11 (7), p.e044921-e044921

2021

Volltextzugriff (PDF)

β‐Cyclodextrin PAMAM Dendrimer: How to Overcome the Tumbling Process for Getting Fully Available Host Cavities

European journal of organic chemistry, 2020-03, Vol.2020 (9), p.1114-1121

2020

Volltextzugriff (PDF)

Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder

Neurology and therapy, 2024-08, Vol.13 (4), p.1081-1098

2024

Volltextzugriff (PDF)

Impairment in circadian activity rhythms occurs during dexamethasone therapy in children with leukemia

Pediatric blood & cancer, 2014-11, Vol.61 (11), p.1986-1991

2014

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(66)
Humans
(58)
Female
(41)
Male
(31)
Adult
(25)
Middle Aged
(22)
Biological And Medical Sciences
(20)
Aged
(19)
Medical Sciences
(18)
Oncology
(17)
Chemotherapy
(13)
Animals
(12)
Lung Neoplasms - Drug Therapy
(11)
Pharmacology. Drug Treatments
(11)
Child
(10)
Risk Factors
(10)
Adolescent
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation

Twice-Weekly Paclitaxel and Weekly Carboplatin With Concurrent Thoracic Radiation Followed by Carboplatin/Paclitaxel Consolidation for Stage III Non–Small-Cell Lung Cancer: A California Cancer Consortium Phase II Trial

Phase I Trial of the Combination of Irinotecan, Paclitaxel, and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma

Phase 2 study of cryptophycin 52 ( LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer

Phase II Study of Liposomal Doxorubicin in Advanced Gynecologic Cancers

Tamoxifen‐associated venous thrombosis and activated protein C resistance due to factor V leiden

Phase II Study of Gemcitabine and Cisplatin in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group Study 9718

Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)

MDR1 gene expression in primary and advanced breast cancer

Gemcitabine in Patients with Non–Small-Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: A Phase II California Cancer Consortium Trial

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II california cancer consortium trial

Phase I/II trial of irinotecan, carboplatin, and paclitaxel in advanced or metastatic NSCLC

Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trial

Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity : a pharmacokinetic and toxicity study

Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections

Bordetella bronchiseptica exploits the complex life cycle of Dictyostelium discoideum as an amplifying transmission vector

A pilot randomized controlled trial to improve sleep and fatigue in children with central nervous system tumors hospitalized for high‐dose chemotherapy

Relationship between circadian activity rhythms and fatigue in hospitalized children with CNS cancers receiving high-dose chemotherapy

Interactions Between the Dietary Polyunsaturated Fatty Acid Ratio and Genetic Factors Determine Susceptibility to Pediatric Crohn's Disease

Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals

β‐Cyclodextrin PAMAM Dendrimer: How to Overcome the Tumbling Process for Getting Fully Available Host Cavities

Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder

Impairment in circadian activity rhythms occurs during dexamethasone therapy in children with leukemia

Suchergebnisse filtern